🚨 Do GLP-1s Really Cause BLINDNESS? Let's Look at the Actual Data
You've seen the terrifying headlines everywhere: "Weight-Loss Drugs Causing Blindness!" "GLP-1s Linked to Eye Damage!"
Time to cut through the fear and look at what the research ACTUALLY shows.
THE STUDIES:
Multiple studies have looked at this, with very different results:
📊 Mass General Brigham Study (2024)
Studied patients at a specialized eye clinic
Found 17 NAION cases in diabetic semaglutide users vs 6 in non-GLP-1 users
HR of 4.28 for diabetes patients
BUT: This was at a neuro-ophthalmology clinic (patients already had eye problems)
📊 Medicare Study (2025)
3.8 MILLION patients aged 65+ with diabetes
NAION occurred in 0.2% over ~4 years
HR of 1.15 for GLP-1s (barely significant)
Insulin had HIGHER risk (HR 1.43)
📊 Multi-Database Study (2025)
37.1 MILLION patients examined
14.5 cases per 100,000 person-years
NO significant difference vs other diabetes drugs
📊 TriNetX Study (2025)
Found NO increased risk (RR 0.7)
5-year risk only 0.065%
Concluded: "lack of association between NAION and GLP-1RAs"
HERE'S THE CONTEXT:
→ NAION = "optic nerve stroke" (vascular, not drug toxicity)
→ Studies are observational only (can't prove causation)
→ Nearly ALL affected patients were diabetic, obese, hypertensive
→ These populations ALREADY at highest risk regardless of meds
→ Absolute risk incredibly low (0.04% to 0.2% in worst studies)
WHO'S GETTING NAION?
The typical profile:
✓ Type 2 diabetes (often poorly controlled)
✓ Hypertension
✓ Obesity
✓ Sleep apnea (major NAION risk factor)
✓ Cardiovascular disease
✓ Older age
This is NOT a healthy population.
WHAT'S REALLY HAPPENING:
When GLP-1s rapidly improve blood sugar, weight, and blood pressure in someone with YEARS of vascular damage, that metabolic shift can temporarily alter blood flow to fragile tissues like the eye.
The drug isn't causing the problem. The pre-existing vascular disease is.
It's like fixing a dam that's about to break - sometimes the repair process reveals existing cracks.
ARE HEALTHY RESEARCH SUBJECTS AT RISK?
Based on all available data: NO.
✅ No RCT data showing risk
✅ No mechanism identified for healthy individuals
✅ No studies of healthy populations showing problems
✅ Some data shows IMPROVED eye health from better glucose control
✅ GLP-1s actually treat many NAION risk factors (hypertension, obesity, inflammation)
THE CONFLICTING DATA:
Why don't all studies agree?
→ Different populations (specialty clinics vs general population)
→ Different study designs
→ Different comparison groups
→ Selection bias (people with problems seek specialized care)
→ Impossible to fully adjust for all vascular risk factors
RESEARCH PROTOCOL BEST PRACTICES:
If you want to be extra cautious:
📋 Baseline eye exam (especially if diabetic/insulin resistant)
⏱️ Titrate slowly - don't jump from 2.5mg to 12.5mg in 8 weeks. Take 12-16 weeks. Let your body adapt.
💊 Support vascular health:
→ SS-31 for mitochondrial function
→ MOTS-c for vascular protection
→ Taurine for endothelial health
→ ARA-290 for microvascular support
😴 Screen for sleep apnea - untreated OSA is a MAJOR independent NAION risk factor
💧 Maintain hydration and electrolytes during rapid weight loss
🏋️ Don't rely on GLP-1s alone - train, eat well, sleep, manage stress
THE BOTTOM LINE:
📰 Headlines: "GLP-1s cause blindness!"
📊 Reality:
→ Absolute risk 0.04-0.2% in diabetic populations (and some studies show ZERO increased risk)
→ Healthy populations: no data suggesting risk
→ Mechanism unclear, causation not proven
→ Studies don't all agree
→ Underlying disease is the real problem
RISK IN PERSPECTIVE:
Out of 1,000 elderly diabetic patients using GLP-1s for 4 years:
2 might develop NAION
998 will NOT
Compare to other accepted risks:
NSAIDs cause thousands of GI bleeds annually
Birth control carries blood clot risk
Statins can cause muscle damage
We accept these because benefits > risks.
You've seen the terrifying headlines everywhere: "Weight-Loss Drugs Causing Blindness!" "GLP-1s Linked to Eye Damage!"
Time to cut through the fear and look at what the research ACTUALLY shows.
THE STUDIES:
Multiple studies have looked at this, with very different results:
📊 Mass General Brigham Study (2024)
Studied patients at a specialized eye clinic
Found 17 NAION cases in diabetic semaglutide users vs 6 in non-GLP-1 users
HR of 4.28 for diabetes patients
BUT: This was at a neuro-ophthalmology clinic (patients already had eye problems)
📊 Medicare Study (2025)
3.8 MILLION patients aged 65+ with diabetes
NAION occurred in 0.2% over ~4 years
HR of 1.15 for GLP-1s (barely significant)
Insulin had HIGHER risk (HR 1.43)
📊 Multi-Database Study (2025)
37.1 MILLION patients examined
14.5 cases per 100,000 person-years
NO significant difference vs other diabetes drugs
📊 TriNetX Study (2025)
Found NO increased risk (RR 0.7)
5-year risk only 0.065%
Concluded: "lack of association between NAION and GLP-1RAs"
HERE'S THE CONTEXT:
→ NAION = "optic nerve stroke" (vascular, not drug toxicity)
→ Studies are observational only (can't prove causation)
→ Nearly ALL affected patients were diabetic, obese, hypertensive
→ These populations ALREADY at highest risk regardless of meds
→ Absolute risk incredibly low (0.04% to 0.2% in worst studies)
WHO'S GETTING NAION?
The typical profile:
✓ Type 2 diabetes (often poorly controlled)
✓ Hypertension
✓ Obesity
✓ Sleep apnea (major NAION risk factor)
✓ Cardiovascular disease
✓ Older age
This is NOT a healthy population.
WHAT'S REALLY HAPPENING:
When GLP-1s rapidly improve blood sugar, weight, and blood pressure in someone with YEARS of vascular damage, that metabolic shift can temporarily alter blood flow to fragile tissues like the eye.
The drug isn't causing the problem. The pre-existing vascular disease is.
It's like fixing a dam that's about to break - sometimes the repair process reveals existing cracks.
ARE HEALTHY RESEARCH SUBJECTS AT RISK?
Based on all available data: NO.
✅ No RCT data showing risk
✅ No mechanism identified for healthy individuals
✅ No studies of healthy populations showing problems
✅ Some data shows IMPROVED eye health from better glucose control
✅ GLP-1s actually treat many NAION risk factors (hypertension, obesity, inflammation)
THE CONFLICTING DATA:
Why don't all studies agree?
→ Different populations (specialty clinics vs general population)
→ Different study designs
→ Different comparison groups
→ Selection bias (people with problems seek specialized care)
→ Impossible to fully adjust for all vascular risk factors
RESEARCH PROTOCOL BEST PRACTICES:
If you want to be extra cautious:
📋 Baseline eye exam (especially if diabetic/insulin resistant)
⏱️ Titrate slowly - don't jump from 2.5mg to 12.5mg in 8 weeks. Take 12-16 weeks. Let your body adapt.
💊 Support vascular health:
→ SS-31 for mitochondrial function
→ MOTS-c for vascular protection
→ Taurine for endothelial health
→ ARA-290 for microvascular support
😴 Screen for sleep apnea - untreated OSA is a MAJOR independent NAION risk factor
💧 Maintain hydration and electrolytes during rapid weight loss
🏋️ Don't rely on GLP-1s alone - train, eat well, sleep, manage stress
THE BOTTOM LINE:
📰 Headlines: "GLP-1s cause blindness!"
📊 Reality:
→ Absolute risk 0.04-0.2% in diabetic populations (and some studies show ZERO increased risk)
→ Healthy populations: no data suggesting risk
→ Mechanism unclear, causation not proven
→ Studies don't all agree
→ Underlying disease is the real problem
RISK IN PERSPECTIVE:
Out of 1,000 elderly diabetic patients using GLP-1s for 4 years:
2 might develop NAION
998 will NOT
Compare to other accepted risks:
NSAIDs cause thousands of GI bleeds annually
Birth control carries blood clot risk
Statins can cause muscle damage
We accept these because benefits > risks.
MY TAKE:
What's consistent:
→ Any signal exists only in high-risk diabetic populations
→ Absolute risk remains extremely low
→ No evidence of harm in healthy people
→ The benefits likely outweigh risks for appropriate patients
For healthy RSs using these compounds responsibly with proper protocols?
The evidence does NOT support significant concern.
📖 Want the FULL breakdown with every study analyzed?
I just published a comprehensive deep-dive on Substack covering:
→ All major studies with actual numbers
→ Why studies conflict
→ The mechanistic theory
→ Who's actually at risk (and who isn't)
→ Complete research protocol recommendations
→ Risk perspective vs other medications
→ What the conflicting data means
→ Read it here: https://open.substack.com/pub/primalsam/p/do-glp-1-drugs-like-semaglutide-and?r=2fl2sn&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
What's consistent:
→ Any signal exists only in high-risk diabetic populations
→ Absolute risk remains extremely low
→ No evidence of harm in healthy people
→ The benefits likely outweigh risks for appropriate patients
For healthy RSs using these compounds responsibly with proper protocols?
The evidence does NOT support significant concern.
📖 Want the FULL breakdown with every study analyzed?
I just published a comprehensive deep-dive on Substack covering:
→ All major studies with actual numbers
→ Why studies conflict
→ The mechanistic theory
→ Who's actually at risk (and who isn't)
→ Complete research protocol recommendations
→ Risk perspective vs other medications
→ What the conflicting data means
→ Read it here: https://open.substack.com/pub/primalsam/p/do-glp-1-drugs-like-semaglutide-and?r=2fl2sn&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
Substack
Do GLP-1 Drugs Like Semaglutide and Tirzepatide Cause Blindness?
What the Research Actually Shows for the Weight Loss Shots and Vision Loss
Media is too big
VIEW IN TELEGRAM
(Lets try this again LOL!) How this weird hack is helping me fight back against inflammation that affects weight, energy, and aging 💧🫧
I've been using molecular hydrogen water daily, and the research behind this is wild.
Studies show molecular hydrogen acts as a selective antioxidant—it targets the most damaging free radicals (hydroxyl radicals) while leaving beneficial ones alone.
This matters for inflammation, which is at the root of stubborn weight, energy crashes, and accelerated aging.
What the research shows:
→ Reduces oxidative stress and systemic inflammation
→ Supports mitochondrial function (hello, energy production)
→ May improve metabolic markers and fat oxidation
→ Enhances cellular repair and skin health
My setup: TheraH2Go Personal Molecular Hydrogen Bottle from Therasage
This thing uses advanced electrolysis to infuse water with molecular hydrogen.
It's the only hydrogen bottle that combines:
🫧 Molecular Hydrogen
🫧 Structured Water
🫧 AND Red Light Technology in one device.
I use it for:
✨ Hydrogen-rich drinking water (metabolism + cellular support)
✨ Hydrogen inhalation (I hacked my existing bottle with a silicone food cover and medical tubing for this—aftermarket DIY style 😂)
Therasage recently released the TheraH2Go+ ("plus" model) with a native inhalation system built in. No hacking or guesswork required.
Why this matters for weight, energy, and skin:
✨ Molecular hydrogen supports mitochondrial function, which means your cells produce energy more efficiently.
✨ Better energy production = better metabolism.
✨ Better metabolism = easier fat burning, stable energy, and cellular repair that shows up in your skin.
Inflammation is the enemy of all three. Hydrogen helps neutralize it at the cellular level.
🫧💸 Therasage sitewide Black Friday sale happening now—and this is one of my top picks.
Here's the discount code that saves you 20% AND can get you a $150 value surprise gift during the sale through my link below: THERAFEST
🔗 TheraH2Go+ Hydrogen Bottle (affiliate): https://bit.ly/48E3PEu
I've been using molecular hydrogen water daily, and the research behind this is wild.
Studies show molecular hydrogen acts as a selective antioxidant—it targets the most damaging free radicals (hydroxyl radicals) while leaving beneficial ones alone.
This matters for inflammation, which is at the root of stubborn weight, energy crashes, and accelerated aging.
What the research shows:
→ Reduces oxidative stress and systemic inflammation
→ Supports mitochondrial function (hello, energy production)
→ May improve metabolic markers and fat oxidation
→ Enhances cellular repair and skin health
My setup: TheraH2Go Personal Molecular Hydrogen Bottle from Therasage
This thing uses advanced electrolysis to infuse water with molecular hydrogen.
It's the only hydrogen bottle that combines:
🫧 Molecular Hydrogen
🫧 Structured Water
🫧 AND Red Light Technology in one device.
I use it for:
✨ Hydrogen-rich drinking water (metabolism + cellular support)
✨ Hydrogen inhalation (I hacked my existing bottle with a silicone food cover and medical tubing for this—aftermarket DIY style 😂)
Therasage recently released the TheraH2Go+ ("plus" model) with a native inhalation system built in. No hacking or guesswork required.
Why this matters for weight, energy, and skin:
✨ Molecular hydrogen supports mitochondrial function, which means your cells produce energy more efficiently.
✨ Better energy production = better metabolism.
✨ Better metabolism = easier fat burning, stable energy, and cellular repair that shows up in your skin.
Inflammation is the enemy of all three. Hydrogen helps neutralize it at the cellular level.
🫧💸 Therasage sitewide Black Friday sale happening now—and this is one of my top picks.
Here's the discount code that saves you 20% AND can get you a $150 value surprise gift during the sale through my link below: THERAFEST
🔗 TheraH2Go+ Hydrogen Bottle (affiliate): https://bit.ly/48E3PEu
This media is not supported in your browser
VIEW IN TELEGRAM
At 32, my doctor told me I was “just tired” and that “this happens to women as they age.”
At Thirty. Two.
I knew something was wrong. My gut, joints, and exhaustion screamed it. But I was gaslit into thinking I was overreacting.
It took years of self-advocacy, research, and refusing to accept “normal aging” as an answer before I finally discovered I had Hashimoto’s, celiac, active methylation mutations, MCAS, and more.
Here’s what I learned: Your instincts are data.
When something feels off in your body, you’re not imagining it. You’re not being dramatic.
You’re not “just stressed.”
This community exists because so many of us have been dismissed, ignored, and told to just accept feeling like garbage.
But we deserve better.
We deserve practitioners who actually listen.
We deserve answers.
We deserve to feel good in our bodies.
If you’re fighting for your health right now and no one is listening - keep going. Find a new doctor. Trust yourself. You’re not crazy.
And to everyone here who shares their journey, asks the hard questions, and refuses to settle - thank you. You’re the reason I get to do this work. You’re the reason other women find their strength.
We all deserve a healthy life. Don’t let anyone convince you otherwise!! 💙
XX, Sam
At Thirty. Two.
I knew something was wrong. My gut, joints, and exhaustion screamed it. But I was gaslit into thinking I was overreacting.
It took years of self-advocacy, research, and refusing to accept “normal aging” as an answer before I finally discovered I had Hashimoto’s, celiac, active methylation mutations, MCAS, and more.
Here’s what I learned: Your instincts are data.
When something feels off in your body, you’re not imagining it. You’re not being dramatic.
You’re not “just stressed.”
This community exists because so many of us have been dismissed, ignored, and told to just accept feeling like garbage.
But we deserve better.
We deserve practitioners who actually listen.
We deserve answers.
We deserve to feel good in our bodies.
If you’re fighting for your health right now and no one is listening - keep going. Find a new doctor. Trust yourself. You’re not crazy.
And to everyone here who shares their journey, asks the hard questions, and refuses to settle - thank you. You’re the reason I get to do this work. You’re the reason other women find their strength.
We all deserve a healthy life. Don’t let anyone convince you otherwise!! 💙
XX, Sam
GLP-1 Washouts: When Your Research Subject Needs a Reset
If you’ve been researching GLP-1s, GIPs, or glucagon peptides for a while, you might be wondering: does my research subject (RS) need a break?
What is a washout?
A washout is a planned break from peptide research to allow the RS’s natural systems to reset. Think of it like giving your body’s metabolic machinery a chance to recalibrate without external signaling.
How long should a washout last?
Typically 4-12 weeks, depending on which peptides were being researched and for how long. Semaglutide and tirzepatide have longer half-lives, so they may warrant longer washouts.
Signs it’s time for a washout:
• Diminishing results despite consistent protocols
• Increased side effects or intolerance
• Metabolic adaptation (reduced appetite suppression, slower weight loss)
• Loss of energy or motivation in the RS
• Desire to assess baseline function
Who benefits most:
RSs who’ve been on protocols for 6+ months, those experiencing plateaus, or those preparing for different research phases. It’s also valuable for RSs wanting to assess their natural metabolic function.
Who might skip it:
RSs with significant health markers still improving, those early in their research journey (under 3-4 months), or those whose protocols are still yielding consistent results.
Peptides to consider researching during GLP washout:
• BPC-157 - gut and tissue repair support
• Thymosin Beta-4 - systemic recovery
• MOTS-c - mitochondrial support and metabolic function
• Epithalon - cellular health and circadian rhythm
• NAD+ boosters - energy production without metabolic suppression
Remember: washouts aren’t failures
They’re strategic resets. Your RS’s body is incredibly adaptive, and sometimes the best research comes from knowing when to pause.
Sources and further reading:
• Lundgren JR, et al. (2021). Glucagon-like peptide 1 receptor agonists and endogenous GLP-1 in the treatment of metabolic syndrome. Peptides
• Müller TD, et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism
• Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM
If you’ve been researching GLP-1s, GIPs, or glucagon peptides for a while, you might be wondering: does my research subject (RS) need a break?
What is a washout?
A washout is a planned break from peptide research to allow the RS’s natural systems to reset. Think of it like giving your body’s metabolic machinery a chance to recalibrate without external signaling.
How long should a washout last?
Typically 4-12 weeks, depending on which peptides were being researched and for how long. Semaglutide and tirzepatide have longer half-lives, so they may warrant longer washouts.
Signs it’s time for a washout:
• Diminishing results despite consistent protocols
• Increased side effects or intolerance
• Metabolic adaptation (reduced appetite suppression, slower weight loss)
• Loss of energy or motivation in the RS
• Desire to assess baseline function
Who benefits most:
RSs who’ve been on protocols for 6+ months, those experiencing plateaus, or those preparing for different research phases. It’s also valuable for RSs wanting to assess their natural metabolic function.
Who might skip it:
RSs with significant health markers still improving, those early in their research journey (under 3-4 months), or those whose protocols are still yielding consistent results.
Peptides to consider researching during GLP washout:
• BPC-157 - gut and tissue repair support
• Thymosin Beta-4 - systemic recovery
• MOTS-c - mitochondrial support and metabolic function
• Epithalon - cellular health and circadian rhythm
• NAD+ boosters - energy production without metabolic suppression
Remember: washouts aren’t failures
They’re strategic resets. Your RS’s body is incredibly adaptive, and sometimes the best research comes from knowing when to pause.
Sources and further reading:
• Lundgren JR, et al. (2021). Glucagon-like peptide 1 receptor agonists and endogenous GLP-1 in the treatment of metabolic syndrome. Peptides
• Müller TD, et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism
• Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM
❤1
GLP-1 Washouts Part 2: What Actually Happens When Your RS Pauses
Let's talk about what I didn't say in yesterday's post.
The real reason research subjects stay on GLP-1 protocols long after they've stopped working: Terror.
You finally found something that worked for your RS when NOTHING else did. After years of trying every diet, every supplement, every protocol—GLP-1s were the first thing that actually moved the needle for your research subject.
Weight dropped. Appetite chaos settled. Maybe for the first time in years, your RS's body felt like it was cooperating instead of sabotaging.
And now the idea of stopping? Even strategically?
It feels like jumping off a cliff.
Here's what no one tells you about washouts:
THE FEAR: "My RS will gain everything back immediately"
The reality: Your research subject's body doesn't work like a light switch.
GLP-1s have long half-lives—sema takes 4-5 weeks to fully clear the system. Tirz takes 3-4 weeks. Your RS isn't going to wake up ravenous on day 2.
What can ACTUALLY happen in a strategic washout:
Weeks 1-2: Appetite might increase slightly, but it's gradual. The peptide is still clearing.
Weeks 3-4: This is where the shift happens. Appetite increases more noticeably. BUT if your RS is supported with the right cellular stack custom-designed for THEM (some examples include BPC-157, TB-500, MOTS-c, KPV, etc), you're addressing the DEEPER dysfunction instead of just white-knuckling through cravings.
Weeks 5-8: The body's recalibrating. This is the crucial window for gut healing and immune modulation—the work that actually changes your RS's metabolic foundation.
Weeks 8-12: You're assessing the new baseline. THIS is where you see if the metabolic changes stuck or if you were just suppressing symptoms.
THE FEAR: "Appetite will come back with a vengeance"
The hard truth: It might. But here's what matters—If your RS's appetite comes roaring back the second the GLP-1 clears, that's INFORMATION.
It means the peptide was suppressing signals, but it wasn't healing the underlying dysfunction:
→ Leptin resistance (satiety signaling is broken)
→ Ghrelin dysregulation (hunger hormones are screaming)
→ Blood sugar instability driving constant cravings
→ Gut inflammation creating food obsession
→ Mitochondrial dysfunction sending false hunger signals (cells starving for energy, not food)
This is EXACTLY why some research subjects need washouts—so you can see what's still broken underneath and address it with cellular healing protocols instead of just suppressing symptoms indefinitely.
THE FEAR: "All progress will be lost"
The reality check: If your RS loses ALL progress the second the GLP-1 stops, that progress wasn't real metabolic healing—it was pharmaceutical suppression.
And here's the hard truth for research subjects with Hashimoto's and autoimmune conditions:
You can't afford to just suppress symptoms. You need actual cellular repair.
GLP-1s are incredible tools for metabolic reset and breaking weight gain cycles. But they're Phase 1, not the forever answer.
What can happen if you DON'T do washouts:
Let me paint the picture of staying on GLP-1s too long without strategic breaks:
Month 6-9: Diminishing returns. Same dose, less effect. Maybe you increase dosing.
Month 10-12: Side effects worsen. Constipation becomes brutal. Reflux is constant. Nausea returns. The RS's gut is SUFFERING (and autoimmune research subjects can't afford more gut damage).
Month 13-18: Metabolic adaptation is complete. The body has compensated. Your RS is plateaued, still taking the peptide, dealing with side effects, spending money on something that's no longer effective.
Month 18+: Trapped. Can't increase (side effects unbearable). Can't decrease (terrified of rebound). Can't progress. Maintaining at best. Not HEALING.
This is the trap strategic washouts prevent.
This is the difference between pharmaceutical dependency and actual metabolic transformation.
Let's talk about what I didn't say in yesterday's post.
The real reason research subjects stay on GLP-1 protocols long after they've stopped working: Terror.
You finally found something that worked for your RS when NOTHING else did. After years of trying every diet, every supplement, every protocol—GLP-1s were the first thing that actually moved the needle for your research subject.
Weight dropped. Appetite chaos settled. Maybe for the first time in years, your RS's body felt like it was cooperating instead of sabotaging.
And now the idea of stopping? Even strategically?
It feels like jumping off a cliff.
Here's what no one tells you about washouts:
THE FEAR: "My RS will gain everything back immediately"
The reality: Your research subject's body doesn't work like a light switch.
GLP-1s have long half-lives—sema takes 4-5 weeks to fully clear the system. Tirz takes 3-4 weeks. Your RS isn't going to wake up ravenous on day 2.
What can ACTUALLY happen in a strategic washout:
Weeks 1-2: Appetite might increase slightly, but it's gradual. The peptide is still clearing.
Weeks 3-4: This is where the shift happens. Appetite increases more noticeably. BUT if your RS is supported with the right cellular stack custom-designed for THEM (some examples include BPC-157, TB-500, MOTS-c, KPV, etc), you're addressing the DEEPER dysfunction instead of just white-knuckling through cravings.
Weeks 5-8: The body's recalibrating. This is the crucial window for gut healing and immune modulation—the work that actually changes your RS's metabolic foundation.
Weeks 8-12: You're assessing the new baseline. THIS is where you see if the metabolic changes stuck or if you were just suppressing symptoms.
THE FEAR: "Appetite will come back with a vengeance"
The hard truth: It might. But here's what matters—If your RS's appetite comes roaring back the second the GLP-1 clears, that's INFORMATION.
It means the peptide was suppressing signals, but it wasn't healing the underlying dysfunction:
→ Leptin resistance (satiety signaling is broken)
→ Ghrelin dysregulation (hunger hormones are screaming)
→ Blood sugar instability driving constant cravings
→ Gut inflammation creating food obsession
→ Mitochondrial dysfunction sending false hunger signals (cells starving for energy, not food)
This is EXACTLY why some research subjects need washouts—so you can see what's still broken underneath and address it with cellular healing protocols instead of just suppressing symptoms indefinitely.
THE FEAR: "All progress will be lost"
The reality check: If your RS loses ALL progress the second the GLP-1 stops, that progress wasn't real metabolic healing—it was pharmaceutical suppression.
And here's the hard truth for research subjects with Hashimoto's and autoimmune conditions:
You can't afford to just suppress symptoms. You need actual cellular repair.
GLP-1s are incredible tools for metabolic reset and breaking weight gain cycles. But they're Phase 1, not the forever answer.
What can happen if you DON'T do washouts:
Let me paint the picture of staying on GLP-1s too long without strategic breaks:
Month 6-9: Diminishing returns. Same dose, less effect. Maybe you increase dosing.
Month 10-12: Side effects worsen. Constipation becomes brutal. Reflux is constant. Nausea returns. The RS's gut is SUFFERING (and autoimmune research subjects can't afford more gut damage).
Month 13-18: Metabolic adaptation is complete. The body has compensated. Your RS is plateaued, still taking the peptide, dealing with side effects, spending money on something that's no longer effective.
Month 18+: Trapped. Can't increase (side effects unbearable). Can't decrease (terrified of rebound). Can't progress. Maintaining at best. Not HEALING.
This is the trap strategic washouts prevent.
This is the difference between pharmaceutical dependency and actual metabolic transformation.
❤1
Questions to evaluate if your RS needs a washout:
✅ Has your RS been on GLP-1 protocol for 6+ months?
✅ Are results diminishing despite consistent protocol?
✅ Are side effects increasing or becoming intolerable?
✅ Are gut issues worsening (constipation, reflux, nausea)?
✅ Has deeper cellular healing been addressed (gut, immune, mitochondria) or just appetite suppression?
✅ Is there an exit strategy or indefinite continuation planned?
If you answered yes to 3+, it might be time to consider a strategic washout.
The real question isn't "will my RS gain weight during a washout?"
The real question is: "What happens if my RS stays stuck on a protocol that stopped working because I'm avoiding the deeper cellular healing work?"
One path: pharmaceutical dependency with diminishing returns and worsening side effects.
The other path: strategic cellular healing and true metabolic transformation.
Washouts aren't failures. They're the strategic move that separates research subjects who plateau from research subjects who actually heal at the cellular level.
Your RS didn't come this far to stay stuck on a peptide that stopped working months ago.
Strategic breaks aren't giving up—they're leveling up!
✅ Has your RS been on GLP-1 protocol for 6+ months?
✅ Are results diminishing despite consistent protocol?
✅ Are side effects increasing or becoming intolerable?
✅ Are gut issues worsening (constipation, reflux, nausea)?
✅ Has deeper cellular healing been addressed (gut, immune, mitochondria) or just appetite suppression?
✅ Is there an exit strategy or indefinite continuation planned?
If you answered yes to 3+, it might be time to consider a strategic washout.
The real question isn't "will my RS gain weight during a washout?"
The real question is: "What happens if my RS stays stuck on a protocol that stopped working because I'm avoiding the deeper cellular healing work?"
One path: pharmaceutical dependency with diminishing returns and worsening side effects.
The other path: strategic cellular healing and true metabolic transformation.
Washouts aren't failures. They're the strategic move that separates research subjects who plateau from research subjects who actually heal at the cellular level.
Your RS didn't come this far to stay stuck on a peptide that stopped working months ago.
Strategic breaks aren't giving up—they're leveling up!
Why eating less isn't working - 3 reasons
When you fix these three sneaky saboteurs, everything else can start falling into place.
Eating less and moving more advice is so 1990s, and honestly? It's keeping you stuck.
🎙 In the newest *5-minute episode*, I'm exposing 3 SNEAKY things sabotaging your weight loss that have NOTHING to do with willpower:
→ Why your late-night eating is hijacking your fat-burning hormones (and the simple sunset rule that fixes it)
→ How going too low carb is actually STRESSING your thyroid and metabolism (yes, really!)
→ The shocking truth about toxins in your anti-aging skincare messing with your weight hormones
Picture this: The weight finally coming off. Your hormones cooperating instead of fighting you. Glowing skin without the toxic load. All from understanding what your body is actually trying to tell you.
This episode is short but packed with actionable fixes you can start TODAY.
No restriction. No suffering. Just smart, ancestral strategies that work WITH your body, not against it.
Listen at the links below – your metabolism will thank you! ✨
Web: https://tinyurl.com/42j76h5v
Apple: https://tinyurl.com/bddfbnrd
*Not medical advice.
When you fix these three sneaky saboteurs, everything else can start falling into place.
Eating less and moving more advice is so 1990s, and honestly? It's keeping you stuck.
🎙 In the newest *5-minute episode*, I'm exposing 3 SNEAKY things sabotaging your weight loss that have NOTHING to do with willpower:
→ Why your late-night eating is hijacking your fat-burning hormones (and the simple sunset rule that fixes it)
→ How going too low carb is actually STRESSING your thyroid and metabolism (yes, really!)
→ The shocking truth about toxins in your anti-aging skincare messing with your weight hormones
Picture this: The weight finally coming off. Your hormones cooperating instead of fighting you. Glowing skin without the toxic load. All from understanding what your body is actually trying to tell you.
This episode is short but packed with actionable fixes you can start TODAY.
No restriction. No suffering. Just smart, ancestral strategies that work WITH your body, not against it.
Listen at the links below – your metabolism will thank you! ✨
Web: https://tinyurl.com/42j76h5v
Apple: https://tinyurl.com/bddfbnrd
*Not medical advice.
Save an additional 15% right now through Friday on GLP-3 with code PRIMALSAM
https://biolongevitylabs.com/?ref=PRIMALSAM
*Research peptides are for research use only, and not specified for human, animal, or in-vivo use.
https://biolongevitylabs.com/?ref=PRIMALSAM
*Research peptides are for research use only, and not specified for human, animal, or in-vivo use.
3 Best Peptides for Your Research Subject During Cold & Flu Season
Cold and flu season hits different when you're trying to keep your research subject functioning at peak capacity. Here are three peptides showing promising results in immune function research:
1. TB-500 (Thymosin Beta-4)
This is the go-to for immune modulation research without overstimulation. TB-500 is a thymic peptide that's been studied extensively for its effects on immune balance and tissue repair.
Research shows TB-500 may enhance the body's ability to respond to viral challenges by supporting:
→ Balanced immune response (modulation vs stimulation)
→ Tissue repair during recovery phases
→ Reduced inflammatory cascade
This is particularly important for research subjects with autoimmune conditions or sensitive immune systems who can't handle immune-stimulating compounds like elderberry or TA-1.
2. BPC-157
While most people think of BPC-157 for tissue repair research, it's also showing interesting results in immune function studies. Research suggests it may support mucosal immunity (your first line of defense) and help modulate inflammatory responses.
Some researchers report their subjects recovering faster from respiratory challenges when BPC-157 is included in protocols.
3. GHK-Cu (Copper Peptide)
This one's fascinating for immune research. GHK-Cu has been studied for its effects on:
→ Anti-inflammatory pathways Tissue regeneration during recovery phases
→ Antioxidant enzyme systems
Research subjects often report improved recovery timelines and reduced severity of symptoms when GHK-Cu is part of their protocol.
Stacking Considerations:
Some researchers combine TB-500 with either BPC-157 or GHK-Cu for synergistic effects. The theory: TA-1 handles immune system modulation while the other peptide supports tissue recovery and inflammation modulation.
Storage Reminder:
All of these are research-use-only peptides. Proper reconstitution with bacteriostatic water and refrigerated storage is essential for maintaining peptide integrity.
What's your research subject's go-to immune support protocol?
Drop your observations below!
For research purposes only. Not intended for human consumption. These statements have not been evaluated by the FDA.
Cold and flu season hits different when you're trying to keep your research subject functioning at peak capacity. Here are three peptides showing promising results in immune function research:
1. TB-500 (Thymosin Beta-4)
This is the go-to for immune modulation research without overstimulation. TB-500 is a thymic peptide that's been studied extensively for its effects on immune balance and tissue repair.
Research shows TB-500 may enhance the body's ability to respond to viral challenges by supporting:
→ Balanced immune response (modulation vs stimulation)
→ Tissue repair during recovery phases
→ Reduced inflammatory cascade
This is particularly important for research subjects with autoimmune conditions or sensitive immune systems who can't handle immune-stimulating compounds like elderberry or TA-1.
2. BPC-157
While most people think of BPC-157 for tissue repair research, it's also showing interesting results in immune function studies. Research suggests it may support mucosal immunity (your first line of defense) and help modulate inflammatory responses.
Some researchers report their subjects recovering faster from respiratory challenges when BPC-157 is included in protocols.
3. GHK-Cu (Copper Peptide)
This one's fascinating for immune research. GHK-Cu has been studied for its effects on:
→ Anti-inflammatory pathways Tissue regeneration during recovery phases
→ Antioxidant enzyme systems
Research subjects often report improved recovery timelines and reduced severity of symptoms when GHK-Cu is part of their protocol.
Stacking Considerations:
Some researchers combine TB-500 with either BPC-157 or GHK-Cu for synergistic effects. The theory: TA-1 handles immune system modulation while the other peptide supports tissue recovery and inflammation modulation.
Storage Reminder:
All of these are research-use-only peptides. Proper reconstitution with bacteriostatic water and refrigerated storage is essential for maintaining peptide integrity.
What's your research subject's go-to immune support protocol?
Drop your observations below!
For research purposes only. Not intended for human consumption. These statements have not been evaluated by the FDA.
Where does disease actually come from?
Everyone's getting sick these days. Cancer, autoimmune stuff, metabolic chaos, heart disease, ADHD, dementia... the list goes on.
And have you noticed how these things overlap? Like someone with one autoimmune condition ends up collecting more. Or how type 2 diabetes becomes a straight shot to Alzheimer's.
The body isn't compartmentalized like conventional medicine wants you to think. It's all connected. But I think it goes deeper than that.
Here's the part that might sound wild:
Most disease has roots in unresolved emotional trauma.
The grudge you can't let go of. The betrayal that still stings. The childhood wound you buried but never actually healed.
These things don't just mess with your head. They mess with your physiology. Over time, they create inflammation, dysfunction, and eventually... disease.
Take cancer research, for example. There's documented evidence linking deep resentment and unresolved anger to cancer development. People holding onto years of bitterness toward someone who wronged them.
Or the autoimmune patient whose body literally attacks itself while they're consumed with rage at someone else.
Or someone with metabolic dysfunction using food to numb emotional pain that's been there since childhood.
Different manifestations. Same root.
So if you're dealing with chronic health issues, ask yourself:
What am I still carrying around emotionally? Who haven't I forgiven? What trauma did I bury instead of processing?
I'm NOT saying stop the peptides, stop the ancestral eating, stop the biohacking. Keep doing all that.
But also look at what's going on underneath. What you've shoved down and refused to deal with.
You might be surprised by what you find, my friend. <3
Not medical advice.
Everyone's getting sick these days. Cancer, autoimmune stuff, metabolic chaos, heart disease, ADHD, dementia... the list goes on.
And have you noticed how these things overlap? Like someone with one autoimmune condition ends up collecting more. Or how type 2 diabetes becomes a straight shot to Alzheimer's.
The body isn't compartmentalized like conventional medicine wants you to think. It's all connected. But I think it goes deeper than that.
Here's the part that might sound wild:
Most disease has roots in unresolved emotional trauma.
The grudge you can't let go of. The betrayal that still stings. The childhood wound you buried but never actually healed.
These things don't just mess with your head. They mess with your physiology. Over time, they create inflammation, dysfunction, and eventually... disease.
Take cancer research, for example. There's documented evidence linking deep resentment and unresolved anger to cancer development. People holding onto years of bitterness toward someone who wronged them.
Or the autoimmune patient whose body literally attacks itself while they're consumed with rage at someone else.
Or someone with metabolic dysfunction using food to numb emotional pain that's been there since childhood.
Different manifestations. Same root.
So if you're dealing with chronic health issues, ask yourself:
What am I still carrying around emotionally? Who haven't I forgiven? What trauma did I bury instead of processing?
I'm NOT saying stop the peptides, stop the ancestral eating, stop the biohacking. Keep doing all that.
But also look at what's going on underneath. What you've shoved down and refused to deal with.
You might be surprised by what you find, my friend. <3
Not medical advice.
Why NAD+ Research May Fall Short (And The Missing Piece)
Let's talk about something that's been frustrating a lot of research subjects lately.
You're investing in NAD+ protocols, expecting that cellular energy boost, mental clarity, and metabolic optimization... but the results? Underwhelming at best.
Sound familiar?
Here's what most people don't realize: NAD+ alone might not be enough.
The NAD+ Saboteur You've Never Heard Of
There's an enzyme called NNMT (Nicotinamide N-Methyltransferase) that's basically hijacking your NAD+ before your cells can use it.
Think of it like this: you're filling up your gas tank, but there's a leak draining it faster than you can fill it. That's NNMT in action.
This enzyme methylates nicotinamide (a key NAD+ building block), making it completely useless for NAD+ production. So even if research subjects are using 100mg, 200mg, or higher doses, much of it gets wasted if NNMT levels are elevated.
This is why some research subjects report "NAD+ doesn't work for me." It's not that the compound is ineffective. It's that NNMT is blocking cellular utilization.
Enter 5-Amino-1MQ: The NNMT Inhibitor
5-Amino-1MQ is a small molecule that inhibits NNMT. It essentially stops the leak so your cells can actually use the NAD+ you're providing.
The research is compelling. A 2022 study in Diabetes, Obesity, and Metabolism showed that NNMT inhibition in research models increased energy expenditure by 10%, reduced fat mass, and improved glucose metabolism without any dietary changes.
Other studies have demonstrated improvements in muscle strength, reduced brain inflammation, and enhanced mitochondrial function (your cellular power plants).
What This Means For Research Subjects:
✅ More NAD+ available for cellular energy, DNA repair, and metabolic function
✅ Enhanced metabolic rate and easier fat loss
✅ Improved brain function and muscle recovery
✅ Stronger anti-aging effects at the cellular level
Injectable vs. Oral: What Research Shows
Injectable 5-Amino-1MQ offers nearly 100% bioavailability. This means it goes straight into the system to inhibit NNMT immediately.
Oral forms work but require significantly higher doses. Why? Because they have to pass through the liver first, where some of it gets broken down.
For research subjects seeking maximum results, injectable protocols show superior outcomes.
The Bottom Line
NAD+ research can be hit or miss for subjects. The missing variable? NNMT activity.
By inhibiting NNMT with 5-Amino-1MQ, research subjects allow their cells to fully utilize NAD+. This leads to better energy production, improved metabolic function, faster recovery, and sharper thinking.
This stack represents one of the most powerful cellular optimization protocols available for research purposes.
If you've been frustrated with NAD+ RESEARCH results, 5-Amino-1MQ could be the missing piece!.
XX, Sam 💜
Let's talk about something that's been frustrating a lot of research subjects lately.
You're investing in NAD+ protocols, expecting that cellular energy boost, mental clarity, and metabolic optimization... but the results? Underwhelming at best.
Sound familiar?
Here's what most people don't realize: NAD+ alone might not be enough.
The NAD+ Saboteur You've Never Heard Of
There's an enzyme called NNMT (Nicotinamide N-Methyltransferase) that's basically hijacking your NAD+ before your cells can use it.
Think of it like this: you're filling up your gas tank, but there's a leak draining it faster than you can fill it. That's NNMT in action.
This enzyme methylates nicotinamide (a key NAD+ building block), making it completely useless for NAD+ production. So even if research subjects are using 100mg, 200mg, or higher doses, much of it gets wasted if NNMT levels are elevated.
This is why some research subjects report "NAD+ doesn't work for me." It's not that the compound is ineffective. It's that NNMT is blocking cellular utilization.
Enter 5-Amino-1MQ: The NNMT Inhibitor
5-Amino-1MQ is a small molecule that inhibits NNMT. It essentially stops the leak so your cells can actually use the NAD+ you're providing.
The research is compelling. A 2022 study in Diabetes, Obesity, and Metabolism showed that NNMT inhibition in research models increased energy expenditure by 10%, reduced fat mass, and improved glucose metabolism without any dietary changes.
Other studies have demonstrated improvements in muscle strength, reduced brain inflammation, and enhanced mitochondrial function (your cellular power plants).
What This Means For Research Subjects:
✅ More NAD+ available for cellular energy, DNA repair, and metabolic function
✅ Enhanced metabolic rate and easier fat loss
✅ Improved brain function and muscle recovery
✅ Stronger anti-aging effects at the cellular level
Injectable vs. Oral: What Research Shows
Injectable 5-Amino-1MQ offers nearly 100% bioavailability. This means it goes straight into the system to inhibit NNMT immediately.
Oral forms work but require significantly higher doses. Why? Because they have to pass through the liver first, where some of it gets broken down.
For research subjects seeking maximum results, injectable protocols show superior outcomes.
The Bottom Line
NAD+ research can be hit or miss for subjects. The missing variable? NNMT activity.
By inhibiting NNMT with 5-Amino-1MQ, research subjects allow their cells to fully utilize NAD+. This leads to better energy production, improved metabolic function, faster recovery, and sharper thinking.
This stack represents one of the most powerful cellular optimization protocols available for research purposes.
If you've been frustrated with NAD+ RESEARCH results, 5-Amino-1MQ could be the missing piece!.
XX, Sam 💜
❤1
NAD+
https://royal-peptides.com/shop/nad-500mg-vial-kit-buffered/?ref=vmjhwxvl
Use code ROYAL10 off your order (expires soon)!
Expired? Use code PRIMALSAM for 10% off your 1st order. :-)
*Research use only. Not for use in humans or animals.
https://royal-peptides.com/shop/nad-500mg-vial-kit-buffered/?ref=vmjhwxvl
Use code ROYAL10 off your order (expires soon)!
Expired? Use code PRIMALSAM for 10% off your 1st order. :-)
*Research use only. Not for use in humans or animals.
5-Amino-1MQ
https://royal-peptides.com/shop/5-amino-1mq/?ref=vmjhwxvl
Use code ROYAL10 off your order!
Expired? Use code PRIMALSAM for 10% off your 1st order. :-)
*Research use only. Not for use in humans or animals.
https://royal-peptides.com/shop/5-amino-1mq/?ref=vmjhwxvl
Use code ROYAL10 off your order!
Expired? Use code PRIMALSAM for 10% off your 1st order. :-)
*Research use only. Not for use in humans or animals.
❤1